FranΓ§aisπ See the interactive version (live chart) β
For Axalta, we replayed every analyst price target of the past 12 months and measured the real outcome: 35% were profitable, average return +10% (128 calls). At 3 months: +5% average return (51% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Keybanc | 19 | 53% | +16% |
| Mizuho | 13 | 31% | +5% |
| Credit Suisse | 11 | 36% | +9% |
| Citigroup | 10 | 20% | +7% |
| RBC Capital | 10 | 40% | +9% |
Is Axalta overvalued, and is it a good time to buy Axalta right now? If you're wondering, here's a recap to make up your own mind: Axalta's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Axalta | Sector median (Materials) |
|---|---|---|
| P/E | 22.5 | 23.4 |
| Forward P/E | 12.9 | 15.9 |
| Net margin | 7% | 8% |
π Axalta is valued in line with its sector (22.5 vs 23.4).
π P/E, PEG, marginβ¦: see the glossary
The analyst consensus on Axalta (AXTA) is "Hold" (13 bullish, 0 bearish calls over 12 months). This is not advice: historically, 35% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $37.00 (+1% vs $36.69), ranging from $30.00 to $42.00 (7 analysts).
Over 1 year, 35% of analyst targets on Axalta were profitable, for an average return of +10% (across 128 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $37.00 within 12 months, i.e. +1% vs the current price. The most bullish targets $42.00, the most cautious $30.00.
Note: analyst targets are 12-month (median $37.00, +1%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (35%), and the stock's past trajectory.
Its P/E is 22.5, forward P/E 12.9. A forward P/E lower than the current P/E means earnings are expected to grow.
π See the full interactive analysis of Axalta β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.